ACIP Presentation Slides: October 2020 Meeting

We will add links to presentations as they are available.

October 28, 2020

Welcome & Introductions

• Welcome and Introductions pdf icon[8 pages, 508]
  Dr. A Cohn
  Dr. J Romero

Immunization Schedules

• Proposed changes to 2021 adult immunization schedule [50 pages]
  Dr. M Freedman

Seasonal Influenza Vaccines

• Introduction pdf icon[5 pages]
  Dr. K Talbot
• Efficacy of cell-derived quadrivalent influenza vaccine (Flucelvax Quadrivalent) in children & adolescents ≥2 years to <18 years old pdf icon[13 pages]
  Dr. G Sylvester
• Influenza Disease Burden and Vaccine Impact Estimates, 2019-20 Season pdf icon[21 pages]
  Dr. C Reed
• End-of-Season Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness against Medically Attended Influenza from three U.S. Networks pdf icon[35 pages]
  Dr. L Grohskopf
• Updates and WG Considerations [1 page]
  Dr. L Grohskopf

Orthopoxvirus Vaccine

• Introduction [10 pages]
  Dr. B Bell
• Orthopoxvirus work group background [25 pages]
  Dr. B Petersen
• JYNNEOS® (MVA-BN®) Smallpox and Monkeypox Vaccine [25 pages]
  Dr. H Weidenthaler
• Variola virus plaque reduction neutralization assay for the assessment of JYNNEOS^(TM) vaccinee sera [10 pages]
  Dr. C Hutson
• Vaccinating against monkeypox in the Democratic Republic of the Congo with JYNNEOS^(TM) [22 pages]
  Dr. B Petersen
• Next Steps [11 pages]
  Dr. A Rao

Dengue Vaccines

• Introduction pdf icon[12 pages, 508]
  Dr. R Atmar

Pneumococcal Vaccines

• Introduction pdf icon[19 pages, 508]
  Dr. K Poehling
  Dr. M Kobayashi
  

Cholera Vaccines

• Introduction pdf icon[7 pages, 508]
  Dr. P Sanchez
  

October 29, 2020

Zoster Vaccine

• Introduction pdf icon[8 pages, 508]
  Dr. G Lee
• Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix) pdf icon[13 pages, 508]
  Dr. J Su
• Vaccine Safety Datalink (VSD) update on post-licensure safety monitoring of RZV pdf icon[11 pages, 508]
  Dr. J Nelson
• Risk of Guillain-Barré syndrome following herpes zoster pdf icon[21 pages, 508]
  Dr. T Anderson
• Summary and planned risk-benefit analysis regarding use of RZV in immunocompetent adults pdf icon[9 pages, 508]
  Dr. T Anderson

Tick-borne Encephalitis Vaccine

• Introduction & Overview of tick-borne encephalitis (TBE) and TBE vaccine pdf icon[17 pages, 508]
  Dr. G Lee
  Dr. S Hill
• Immunogenicity and safety of Pfizer’s TBE vaccine & Next steps for TBE vaccine work group pdf icon[53 pages, 508]
  Dr. H Schmitt
  Dr. S Hill

Rabies Vaccine

• Introduction pdf icon[9 pages, 508]
  Dr. S Frey
• Rabies Pre-exposure Prophylaxis in the United States and Work Group Considerations pdf icon[22 pages]
  Dr. A Rao
• Minimum acceptable rabies antibody titer pdf icon[17 pages, 508]
  Dr. S Moore
• Pertinent fundamentals of rabies immunology pdf icon[19 pages, 508]
  Dr. D Briggs
• Pre-exposure prophylaxis schedule: Grading of recommendations assessment, development, and evaluation (GRADE) pdf icon[46 pages, 508]
  Dr. A Rao
• Evidence to recommendation framework (EtR) pdf icon[64 pages, 508]
  Dr. A Rao
• Summary and next steps pdf icon[15 pages, 508]
  Dr. A Rao

October 30, 2020

Coronavirus Disease 2019 (COVID-19) Vaccines

• Introduction pdf icon[14 pages, 508]
  Dr. B Bell
• Update from Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting pdf icon[17 pages, 508]
  Dr. D Fink
• NVX-CoV2373 Vaccine Candidate pdf icon[21 Pages]
  Dr. F Dubovsky
• Janssen’s SARS-CoV-2 Vaccine Program pdf icon[15 pages]
  Dr. J Sadoff
• Update on vaccine implementation planning pdf icon[14 pages, 508]
  Dr. J Routh
• Vaccinate with Confidence pdf icon[11 pages, 508]
  Dr. A Cohn
• FDA safety surveillance systems pdf icon[24 pages, 508]
  Dr. S Anderson
• Post-authorization safety monitoring plans pdf icon[31 pages, 508]
  Dr. T Shimabukuro
• Modeling strategies for the initial allocation of COVID-19 vaccines pdf icon[28 pages, 508]
  Dr. M Biggerstaff
• Updates to immunity and epidemiology to inform COVID-19 vaccine policy pdf icon[57 pages, 508]
  Dr. M Wallace
• Ethical principles for early vaccine allocation pdf icon[22 pages, 508]
  Dr. M Chamberland
• Work Group interpretation of data pdf icon[17 pages, 508]
  Dr. S Oliver
• Policy questions, Evidence to Recommendation Framework, and Outcomes pdf icon[11 pages, 508]
  Dr. K Dooling
• ACIP COVID-19 Vaccine Safety Technical Sub-Group pdf icon[6 pages, 508]
  Dr. M Wharton